Ha habido 50 transacciones internas recientes registradas para Foghorn Therapeutics Inc. (FHTX), incluyendo 34 compras y 6 ventas. El total de compras internas fue valorado en $45.94M y el total de ventas internas en $781.16K.
Internos destacados con actividad reciente incluyen Maynard Ryan D, Gottschalk Adrian, Cardama Alfonso Quintas. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — FHTX
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-02-23 |
Maynard Ryan D |
Officer |
Desconocido |
- |
- |
- |
- |
| 2026-02-23 |
Maynard Ryan D |
Chief Financial Officer |
Concesión de RSU |
400,000 |
$5.75 |
$2.3M |
400,000 |
| 2026-02-05 |
Gottschalk Adrian |
Chief Executive Officer |
Concesión de RSU |
1,075,000 |
$5.23 |
$5.62M |
1,075,000 |
| 2026-01-30 |
Cardama Alfonso Quintas |
Chief Medical Officer |
Concesión de RSU |
300,000 |
$5.71 |
$1.71M |
300,000 |
| 2026-01-30 |
Bellon Steven F. |
Chief Scientific Officer |
Concesión de RSU |
300,000 |
$5.71 |
$1.71M |
300,000 |
| 2026-01-30 |
Lacascia Michael |
Chief Legal Officer |
Concesión de RSU |
295,000 |
$5.71 |
$1.68M |
295,000 |
| 2026-01-30 |
Costa Carlos |
Chief People Officer |
Concesión de RSU |
230,000 |
$5.71 |
$1.31M |
230,000 |
| 2026-01-30 |
Rivkin Anna |
Chief Business Officer |
Concesión de RSU |
165,000 |
$5.71 |
$942.15K |
165,000 |
| 2026-01-13 |
Flagship Pioneering, Llc |
10 Percent Owner |
Concesión de RSU |
1,117,734 |
$20.13 |
$22.5M |
1,117,734 |
| 2025-11-14 |
Humer Kristian |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-06-17 |
Parshall B Lynne |
Director |
Concesión de RSU |
25,000 |
$4.79 |
$119.75K |
25,000 |
| 2025-06-17 |
Gill Simba |
Director |
Concesión de RSU |
25,000 |
$4.79 |
$119.75K |
25,000 |
| 2025-06-17 |
Smith Ian F |
Director |
Concesión de RSU |
25,000 |
$4.79 |
$119.75K |
25,000 |
| 2025-06-17 |
Lynch Thomas J. Jr. |
Director |
Concesión de RSU |
25,000 |
$4.79 |
$119.75K |
25,000 |
| 2025-06-17 |
Cole Douglas G. |
Director |
Concesión de RSU |
25,000 |
$4.79 |
$119.75K |
25,000 |
| 2025-06-17 |
Biller Scott |
Director |
Concesión de RSU |
25,000 |
$4.79 |
$119.75K |
25,000 |
| 2025-06-17 |
Mendelsohn Michael |
Director |
Concesión de RSU |
25,000 |
$4.79 |
$119.75K |
25,000 |
| 2025-05-01 |
Duty Stuart |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-05-01 |
Duty Stuart |
Director |
Concesión de RSU |
50,000 |
$4.16 |
$208K |
50,000 |
| 2025-05-01 |
Gallagher Neil |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-05-01 |
Gallagher Neil |
Director |
Concesión de RSU |
50,000 |
$4.16 |
$208K |
50,000 |
| 2025-04-25 |
Gottschalk Adrian |
Chief Executive Officer |
Donación (Recibida) |
300,000 |
- |
- |
511,704 |
| 2025-04-09 |
Gottschalk Adrian |
Chief Executive Officer |
Donación (Recibida) |
197,906 |
- |
- |
511,704 |
| 2025-01-22 |
Cardama Alfonso Quintas |
Chief Medical Officer |
Concesión de RSU |
125,000 |
$4.37 |
$546.25K |
125,000 |
| 2025-01-22 |
Gottschalk Adrian |
Chief Executive Officer |
Concesión de RSU |
400,000 |
$4.37 |
$1.75M |
400,000 |
| 2025-01-22 |
Bellon Steven F. |
Chief Scientific Officer |
Concesión de RSU |
140,000 |
$4.37 |
$611.8K |
140,000 |
| 2025-01-22 |
Lacascia Michael |
Chief Legal Officer |
Concesión de RSU |
126,000 |
$4.37 |
$550.62K |
126,000 |
| 2025-01-22 |
Humer Kristian |
Chief Financial Officer |
Concesión de RSU |
120,000 |
$4.37 |
$524.4K |
120,000 |
| 2025-01-22 |
Costa Carlos |
Chief People Officer |
Concesión de RSU |
115,000 |
$4.37 |
$502.55K |
115,000 |
| 2025-01-22 |
Rivkin Anna |
Chief Business Officer |
Concesión de RSU |
50,000 |
$4.37 |
$218.5K |
50,000 |
| 2024-12-29 |
Koppel Adam |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-09-23 |
Costa Carlos |
Chief People Officer |
Venta Informativa |
857 |
$10.17 |
$8.72K |
- |
| 2024-09-20 |
Costa Carlos |
Chief People Officer |
Venta Informativa |
35,756 |
$10.04 |
$358.99K |
- |
| 2024-09-18 |
Costa Carlos |
Chief People Officer |
Venta Informativa |
11,574 |
$10.05 |
$116.32K |
- |
| 2024-09-17 |
Costa Carlos |
Chief People Officer |
Venta Informativa |
10,272 |
$10.04 |
$103.13K |
- |
| 2024-09-16 |
Costa Carlos |
Chief People Officer |
Venta Informativa |
400 |
$10.00 |
$4K |
- |
| 2024-09-09 |
Bellon Steven F. |
Chief Scientific Officer |
Venta Informativa |
20,000 |
$9.50 |
$190K |
101,957 |
| 2024-09-03 |
Rivkin Anna |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-09-03 |
Rivkin Anna |
Chief Business Officer |
Concesión de RSU |
190,000 |
$7.85 |
$1.49M |
190,000 |
| 2024-06-26 |
Parshall B Lynne |
Director |
Concesión de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-26 |
Gill Simba |
Director |
Concesión de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-26 |
Smith Ian F |
Director |
Concesión de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-26 |
Lynch Thomas J. Jr. |
Director |
Concesión de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-26 |
Cole Douglas G. |
Director |
Concesión de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-26 |
Koppel Adam |
Director |
Concesión de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-26 |
Biller Scott |
Director |
Concesión de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-26 |
Mendelsohn Michael |
Director |
Concesión de RSU |
16,000 |
$5.52 |
$88.32K |
16,000 |
| 2024-06-21 |
Cavalie Fanny |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-05-22 |
Flagship Pioneering Inc. |
10 Percent Owner |
Compra Informativa |
1,814,914 |
$0.00 |
$181.49 |
1,814,914 |
| 2024-05-22 |
Flagship Pioneering Fund Vii General Partner Llc |
10 Percent Owner |
Desconocido |
1,814,915 |
$0.00 |
$181.49 |
- |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
